Discover how Inspire successfully recruited and engaged patients for a fully decentralized clinical study—demonstrating the power of digital health communities to support real-world, self-directed research.
This case study details how Inspire recruited 200 patients taking GLP-1 therapies (tirzepatide or semaglutide) and achieved high engagement, survey completion, and at-home blood collection—proving decentralized research is not only feasible but scalable.
Case Study Highlights Include:
- Fully Digital Study Execution
Learn how Inspire recruited, consented, and guided patients through a virtual protocol—including baseline, 30-day diaries, and follow-up surveys. - High Adherence and Completion Rates
75% of participants completed all study tasks, including complex actions like daily symptom tracking and at-home blood draws using TAP Micro devices. - Quality Data Collection at Scale
71% of returned blood samples were usable for analyte testing, reinforcing the scientific viability of community-sourced, decentralized protocols.
This downloadable case study is ideal for research teams, clinical ops leaders, and digital health innovators exploring how online patient communities can power decentralized clinical trials and real-world evidence generation.